6th Global Pharma SFE Forum

Fleming Europe15 - 16 March 2011, Lisbon, Portugal.
Following the previous five successful SFE conferences, Fleming Europe announced the 6th Pharma SFE Forum. The conventional conference program has been changed to interactive simulation games, case studies discussions, panel and round table sessions. Global Pharma SFE Forum is focused solely on interaction between attendees and expert presenters.

The 2 Focused Streams (Sales, Marketing, CRM, HR, and Training) will consist of Hands-on Case Studies, Workshops, Simulation presentations and Panel discussions.

Case Studies:

  • Detect Recent Trends and Future of Commercial Model
  • Targeting Effectiveness with right Metrics
  • How to Enjoy Change? Challenge of Merger- Acquisition Process
  • Where do you Spend your Promotional Dollar?
  • Using Marketing Simulation to Drive Brand Awareness
  • Innovative Approaches for Creative Marketing and Increasing Sales Trough Diverse, Multi Channel Initiatives
  • Hiring Pharma Sales Reps: Getting the Process Right
  • The Evolving Training Needs of Pharma Sales Force
  • What they "do" they learn: Most Effective Training For Your Sales Force "Simulation Gaming"
  • Achieving a CRM project success
  • Sales Territory Analysis and Optimization
  • Overcoming Restricted Access to Physicians
  • Using Technology to achieve sales force effectiveness
  • Determining Sales Force Size
  • Motivating and Compensating the Sales Force
  • Discovering Proven Methods to Measure the Impact of your Incentives
  • Value your Sales Talents, Cultural Differences

Workshops:

  • Use the opportunity to interact with presenters face-to-face to ask your questions and brainstorm with your peers.

Keynote:

  • Brand-New Holistic Approach of Pharmaceutical Sales Model

Fleming Europe has gathered almost 20 Vice Presidents, Global Heads and Senior Directors. A special part is an evening event to discover Lisbon and enjoy its finest spring hour.

For further information and registration, please visit:
http://www.sfeforum.com

About Fleming Europe conferences
Fleming Europe conferences are events linking business with intelligence. Carefully designed to provide key strategic business information and the best networking opportunities for the participants, our B2B conferences are highly interactive. Number of delegates from specialized industry sectors - brought together by Fleming Europe - become part of a premium community discussing the questions of the day and enjoying the value of a five star event.

Most Popular Now

AstraZeneca amends collaboration with Ironwood for…

AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau for Linzess (linaclo...

Cause of antibiotic resistance identified

Scientists have confirmed for the first time that bacteria can change form to avoid being detected by antibiotics in the human body. Studying samples from elderly patient...

Bayer, Brigham and Women’s Hospital, and Massachus…

Bayer and Partners HealthCare's founding members Brigham and Women's Hospital (BWH) and Massachusetts General Hospital (MGH) today announced the launch of a joint lab to ...

FDA grants Fast Track designation for Farxiga in h…

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of Farxiga (dapagliflozin) to reduce the risk ...

Amgen announces positive results from two Phase 3 …

Amgen (NASDAQ:AMGN) today announced that the results of a prespecified interim analysis of an open-label, randomized, controlled global multicenter Phase 3 trial (2012021...

Brilinta monotherapy in high-bleeding risk patient…

New data from TWILIGHT, a Phase IV independent trial (funded by AstraZeneca), showed that in patients at high-bleeding risk who underwent PCI and completed 3 months of du...

Gene-targeted cancer drugs, slow release overcome …

Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, prot...

Educational campaign helps teens and their caregiv…

Teenagers face many challenges, and growing up with a chronic skin disease called atopic dermatitis (AD) can impact the ups and downs and transitions to young adulthood. ...

Study points to new drug target in fight against c…

Researchers have identified a potential new drug target in the fight against cancer. In a study this week in the Proceedings of the National Academy of Sciences, an inter...

AstraZeneca divests rights for Losec to Cheplaphar…

AstraZeneca has agreed to sell the global commercial rights, excluding China, Japan, the US and Mexico, for Losec (omeprazole) and associated brands to Cheplapharm Arznei...

Cheaper drug just as effective protecting heart in…

A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in...

Dengue virus becoming resistant to vaccines and th…

Researchers from Duke-NUS Medical School (DukeNUS), in collaboration with the Agency for Science, Technology and Research (A*STAR)'s Bioinformatics Institute (BII), and t...